Fact.MR: Rising Prevalence of Cancer Necessitate Robust Epigenetics Market Demand by 10.9% CAGR through 2032
Epigenetics Demand Fueled by Increased Development of Oncology Biomarkers, Valuation to Reach US$ 2.79 Billion by 2032 Fact.MR's recent study published on the global epigenetics market